Finance

Lists
BDX:NYSE
Becton Dickinson and Co
187,37 USD
-0,80%
(-1,52) 1D
187,37 USD
0,00% (0,00)
After hours
Closed: 13-окт., 16:00:10 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDX...
Open
189,82 USD
High
189,99 USD
Low
185,59 USD
Mkt. cap
51,04 млд
Avg. vol.
1,78 млн
Volume
16,00
Dividend
2,24%
Quarterly dividend
1,05 USD
Ex-dividend date
2026-ж., 9-сен.
P/E ratio
56,60
52-wk high
193,07 USD
52-wk low
127,54 USD
EPS
3,31 USD
Beta
0,21
Shares outstanding
272,39 млн
No. of employees
72 миң
Open
189,82 USD
High
189,99 USD
Low
185,59 USD
Mkt. cap
51,04 млд
Avg. vol.
1,78 млн
Volume
16,00
Dividend
2,24%
Quarterly dividend
1,05 USD
Ex-dividend date
2026-ж., 9-сен.
P/E ratio
56,60
52-wk high
193,07 USD
52-wk low
127,54 USD
EPS
3,31 USD
Beta
0,21
Shares outstanding
272,39 млн
No. of employees
72 миң
News stories
From web sources and news partners
Profile
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
About Becton Dickinson and Co
CEOThomas Polen
Employees72 миң
Founded1897
HeadquartersФранклин Лейкс, Нью Джерси, Америка Кошмо Штаттары
SectorMedical device
Websitebd.com
Analyst ratings
Based on 10 analysts giving stock ratings to BDX in the past 3 months
Buy
Buy
4
Hold
5
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BDX in the last 3 months.
Highest
Current 187,37 USD
210,00 USD (+12,08%)
Average
191,80 USD (+2,36%)
Lowest
165,00 USD (-11,94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Hold
Maintained
200,00 USD
+6,7%
10/06/2026
Christopher Pasquale
Barclays
Sell
Initiated
165,00 USD
-11,9%
10/07/2026
Matt Miksic
Barclays
Sell
Maintained
165,00 USD
-11,9%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
208,00 USD
+11%
10/05/2026
Kendall Au
RBC Capital
Hold
Maintained
190,00 USD
+1,4%
10/01/2026
Matthew Taylor
Jefferies
Buy
Maintained
210,00 USD
+12,1%
09/08/2026
Josh Jennings
TD Cowen
Hold
Reiterated
182,00 USD
-2,9%
08/17/2026
Patrick Wood
UBS
Buy
Reiterated
205,00 USD
+9,4%
08/12/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
188,00 USD
+0,3%
08/10/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
195,00 USD
+4,1%
08/11/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
175,00 USD
-6,6%
08/07/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
180,00 USD
-3,9%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
180,00 USD
-3,9%
07/06/2026
David Roman
Goldman Sachs
Hold
Initiated
167,00 USD
-10,9%
04/10/2026
David Toung
Argus Research
Buy
Reiterated
180,00 USD
-3,9%
03/20/2026
Unknown Analyst
Jefferies
Buy
Maintained
190,00 USD
+1,4%
02/10/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
175,00 USD
-6,6%
02/10/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
157,00 USD
-16,2%
02/10/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q3 2026
3,23 USD / 3,14 USD
+2,93%beat
Revenue / Est. (USD)
4,98 млд / 4,89 млд
+1,91%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,89 млд
4,49 млд
4,71 млд
4,98 млд
Cost of goods sold
3,09 млд
2,43 млд
2,56 млд
2,67 млд
Cost of revenue
3,09 млд
2,43 млд
2,56 млд
2,67 млд
Research and development expenses
322,00 млн
235,00 млн
249,00 млн
258,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,43 млд
1,23 млд
1,24 млд
1,27 млд
Operating expense
1,75 млд
1,46 млд
1,46 млд
1,53 млд
Total operating expenses
4,84 млд
3,90 млд
4,02 млд
4,20 млд
Operating income
1,05 млд
590,00 млн
695,00 млн
784,00 млн
Other non operating income
92,00 млн
-12,00 млн
109,00 млн
30,00 млн
EBT including unusual items
510,00 млн
311,00 млн
39,00 млн
553,00 млн
EBT excluding unusual items
947,00 млн
429,00 млн
664,00 млн
686,00 млн
Income tax expense
17,00 млн
-
76,00 млн
102,00 млн
Effective tax rate
3,33%
-
194,87%
18,44%
Other operating expenses
-4,00 млн
1,00 млн
-26,00 млн
-
Net income
493,00 млн
383,00 млн
-311,00 млн
377,00 млн
Net profit margin
8,37%
8,54%
-6,60%
7,57%
Earnings per share
3,96
2,91
2,90
3,23
Interest and investment income
5,00 млн
4,00 млн
9,00 млн
4,00 млн
Interest expense
-155,00 млн
-153,00 млн
-149,00 млн
-132,00 млн
Net interest expenses
-150,00 млн
-149,00 млн
-140,00 млн
-128,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,68 млд
1,20 млд
1,22 млд
1,35 млд
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору